首页 > 资讯 > 氨酰tRNA合成酶作用机制及其应用

氨酰tRNA合成酶作用机制及其应用

泰然健康网
2026-01-21 08:04

［1］Qin X, Hao Z, Tian Q, et al. Cocrystal structures of glycyltRNA synthetase in complex with tRNA suggest multiple conformational states in glycylation［J］. J Biol Chem, 2014, 289(29): 2035920369

［2］Irwin MJ, Nyborg J, Reid BR, et al. The crystal structure of tyrosyltransfer RNA synthetase at 27  resolution［J］. J Mol Biol, 1976, 105(4): 577586

［3］Silvian LF, Wang J, Steitz TA. Insights into editing from an iletRNA synthetase structure with tRNAile and mupirocin［J］. Science, 1999, 285(5430): 10741077

［4］Cvetesic N, Palencia A, Halasz I, et al. The physiological target for LeuRS translational quality control is norvaline［J］. EMBO J, 2014, 33(15): 16391653

［5］Fang P, Han H, Wang J, et al. Structural basis for specific inhibition of tRNA synthetase by an ATP competitive inhibitor［J］. Chem Biol, 2015, 22(6): 734744

［6］Li R, Macnamara LM, Leuchter JD, et al. MD simulations of tRNA and aminoacyltRNA synthetases: dynamics, folding, binding, and allostery［J］. Int J Mol Sci, 2015, 16(7): 1587215902

［7］Heinemann IU, Rovner AJ, Aerni HR, et al. Enhanced phosphoserine insertion during Escherichia coli protein synthesis via partial UAG codon reassignment and release factor 1 deletion［J］. FEBS Lett, 2012, 586(20): 37163722

［8］Kavran JM, Gundllapalli S, O’donoghue P, et al. Structure of pyrrolysyltRNA synthetase, an archaeal enzyme for genetic code innovation［J］. Proc Natl Acad Sci U S A, 2007, 104(27): 1126811273

［9］Tan K, Zhou M, Zhang R, et al. The crystal structures of the alphasubunit of the alpha(2)beta (2) tetrameric GlycyltRNA synthetase［J］. J Struct Funct Genomics, 2012, 13(4): 233239

［10］Perona JJ, GruicSovulj I. Synthetic and editing mechanisms of aminoacyltRNA synthetases［J］. Top Curr Chem, 2014, 344: 141

［11］Fang P, Guo M. Evolutionary limitation and opportunities for developing tRNA synthetase inhibitors with 5bindingmode classification［J］. Life (Basel), 2015, 5(4): 17031725

［12］Boyarshin KS, Priss AE, Rayevskiy AV, et al. A new mechanism of posttransfer editing by aminoacyltRNA synthetases: catalysis of hydrolytic reaction by bacterialtype prolyltRNA synthetase［J］. J Biomol Struct Dyn, 2016, 8: 114

［13］Ling J, Peterson KM, Simonovic I, et al. The mechanism of pretransfer editing in yeast mitochondrial threonyltRNA synthetase［J］. J Biol Chem, 2012, 287
(34): 2851828525

［14］Liu Y, Liao J, Zhu B, et al. Crystal structures of the editing domain of Escherichia coli leucyltRNA synthetase and its complexes with Met and Ile reveal a lockandkey mechanism for amino acid discrimination［J］. Biochem J, 2006, 394(Pt 2): 399407

［15］Cao Z, Wang H, Mao X, et al. Noncanonical function of threonyltRNA synthetase regulates vascular development in zebrafish［J］. Biochem Biophys Res Commun, 2016, 473(1): 6772

［16］Smirnova EV, Lakunina VA, Tarassov I, et al. Noncanonical functions of aminoacyltRNA synthetases［J］. Biochemistry (Mosc), 2012, 77(1): 1525

［17］Sajish M, Schimmel P. A human tRNA synthetase is a potent PARP1activating effector target for resveratrol［J］. Nature, 2015, 519(7543): 370373

［18］Nakama T, Nureki O, Yokoyama S. Structural basis for the recognition of isoleucyladenylate and an antibiotic, mupirocin, by isoleucyltRNA synthetase［J］. J Biol Chem, 2001, 276(50): 4738747393

［19］Vondenhoff GH, Dubiley S, Severinov K, et al. Extended targeting potential and improved synthesis of Microcin C analogs as antibacterials［J］. Bioorg Med Chem, 2011, 19(18): 54625467

［20］Zhou H, Sun L, Yang XL, et al. ATPdirected capture of bioactive herbalbased medicine on human tRNA synthetase［J］. Nature, 2013, 494(7435): 121124

［21］Keller TL, Zocco D, Sundrud MS, et al. Halofuginone and other febrifugine derivatives inhibit prolyltRNA synthetase［J］. Nat Chem Biol, 2012, 8(3): 311317

［22］Fang P, Yu X, Jeong SJ, et al. Structural basis for fullspectrum inhibition of translational functions on a tRNA synthetase［J］. Nat Commun, 2015, 6: 6402

［23］Tworowski D, Klipcan L, Peretz M, et al. Universal pathway for posttransfer editing reactions: insights from the crystal structure of TtPheRS with puromycin［J］. Proc Natl Acad Sci U S A, 2015, 112(13): 39673972

［24］Zhao H, Palencia A, Seiradake E, et al. Analysis of the resistance mechanism of a benzoxaborole inhibitor reveals insight into the LeucyltRNA synthetase editing mechanism［J］. ACS Chem Biol, 2015, 10(10): 22772285

［25］Hu QH, Liu RJ, Fang ZP, et al. Discovery of a potent benzoxaborolebased antipneumococcal agent targeting leucyltRNA synthetase［J］. Sci Rep, 2013, 3: 2475

［26］Kim DG, Lee JY, Kwon NH, et al. Chemical inhibition of prometastatic lysyltRNA synthetaselaminin receptor interaction［J］. Nat Chem Biol, 2014, 10(1): 2934

［27］Wang L, Xie J, Schultz PG. Expanding the genetic code［J］. Annu Rev Biophys Biomol Struct, 2006, 35: 225249

［28］Cooley RB, Feldman JL, Driggers CM, et al. Structural basis of improved secondgeneration 3nitrotyrosine tRNA synthetases［J］. Biochemistry, 2014, 53(12): 19161924

［29］Tanrikulu IC, Schmitt E, Mechulam Y, et al. Discovery of Escherichia coli methionyltRNA synthetase mutants for efficient labeling of proteins with azidonorleucine in vivo［J］. Proc Natl Acad Sci U S A, 2009, 106(36): 1528515290

［30］Schmitt E, Tanrikulu IC, Yoo TH, et al. Switching from an inducedfit to a lockandkey mechanism in an aminoacyltRNA synthetase with modified specificity［J］. J Mol Biol, 2009, 394(5): 843851

［31］Tang Y, Tirrell DA. Attenuation of the editing activity of the Escherichia coli leucyltRNA synthetase allows incorporation of novel amino acids into proteins in vivo［J］. Biochemistry, 2002, 41(34): 1063510645

［32］Oki K, Sakamoto K, Kobayashi T, et al. Transplantation of a tyrosine editing domain into a tyrosyltRNA synthetase variant enhances its specificity for a tyrosine analog［J］. Proc Natl Acad Sci U S A, 2008, 105(36): 1329813303

［33］Neumann H, Hazen JL, Weinstein J, et al. Genetically encoding protein oxidative damage［J］. J Am Chem Soc, 2008, 130(12): 40284033

［34］Franco MC, Ye Y, Refakis CA, et al. Nitration of Hsp90 induces cell death［J］. Proc Natl Acad Sci U S A, 2013, 110(12): E11021111

［35］SorciThomas MG, Thomas MJ. Microdomains, inflammation, and atherosclerosis［J］. Circ Res, 2016, 118(4): 679691

［36］Wang YS, Wu B, Wang Z, et al. A genetically encoded photocaged Nepsilon-methyl-L-lysine［J］. Mol Biosyst, 2010, 6(9): 15571560

［37］Eger S, Castrec B, Hubscher U, et al. Generation of a monoubiquitinated PCNA mimic by click chemistry［J］. Chembiochem, 2011, 12(18): 28072812

［38］Huang Y, Wan W, Russell WK, et al. Genetic incorporation of an aliphatic ketocontaining amino acid into proteins for their sitespecific modifications［J］. Bioorg Med Chem Lett, 2010, 20(3): 878880

［39］Exner MP, Kohling S, Rivollier J, et al. Incorporation of amino acids with longchain terminal olefins into proteins［J］. Molecules, 2016, 21(3): 287

［40］Kobayashi T, Nureki O, Ishitani R, et al. Structural basis for orthogonal tRNA specificities of tyrosyltRNA synthetases for genetic code expansion［J］. Nat Struct Biol, 2003, 10(6): 425432

［41］Park HS, Hohn MJ, Umehara T, et al. Expanding the genetic code of Escherichia coli with phosphoserine［J］. Science, 2011, 333(6046): 11511154

［42］Khan S, Sharma A, Jamwal A, et al. Uneven spread of cisand transediting aminoacyltRNA synthetase domains within translational compartments of P. falciparum［J］. Sci Rep, 2011, 1: 188

［43］Gao F, Shen XZ, Jiang F, et al. DNAguided genome editing using the Natronobacterium gregoryi Argonaute［J］. Nat Biotechnol, 2016, 34(7): 768773

［44］Zhang JH, Adikaram P, Pandey M, et al. Optimization of genome editing through CRISPRCas9 engineering［J］. Bioengineered, 2016, 7(3): 166174